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Mitogen-Activated Protein Kinases (MAPKs) control a wide array of cellular functions by transducing extracellular
information into defined biological responses. In order to understand how these pathways are regulated, dynamic
single cell measurements are highly needed. Fluorescence microscopy is well suited to perform these measure-
ments. However, more dynamic and sensitive biosensors that allow the quantification of signaling activity in
living mammalian cells are required. We have engineered a synthetic fluorescent substrate for human MAPKs
(ERK, JNK and p38) that relocates from the nucleus to the cytoplasm when phosphorylated by the kinases. We
demonstrate that this reporter displays an improved response compared to other relocation biosensors. This assay
allows to monitor the heterogeneity in the MAPK response in a population of isogenic cells, revealing pulses of
ERK activity upon a physiological EGFR stimulation. We show applicability of this approach to the analysis of
multiple cancer cell lines and primary cells as well as its application in vivo to developing tumors. Using this ERK
biosensor, dynamic single cell measurements with high temporal resolution can be obtained. These MAPK re-
porters can be widely applied to the analysis of molecular mechanisms of MAPK signaling in healthy and diseased
state, in cell culture assays or in vivo.1. Introduction
Given that cells live in changing environments, they have developed
complex biochemical networks to sense and transmit extracellular in-
formation. Intensive biological research has allowed the identification of
multiple signal transduction pathways that relay the presence of nutri-
ents, stress or hormones in the cell's surroundings. The biochemical
analysis of these pathways has allowed the identification of the major
players implicated in these processes. However, to fully grasp the com-
plex regulation of these biochemical signals, quantitative and dynamic
measurements have to be performed.
An additional layer of complexity arises from the fact that each cell,
even in an isogenic population, can display different cellular behaviors
[1]. Population-averaged measurements can prevent the identification of
important signaling patterns such as oscillations or bimodality [2, 3].
Therefore, the value of single cell measurements has been generally
recognized. Microscopy and flow cytometry, as well as novel techniques
such as mass cytometry or single cell sequencing, have gained in
importance to unravel the biochemical signals taking place in single cells.
In the signaling field, the dynamics of the biological system is an essentialOctober 2020; Accepted 18 Nov
vier Ltd. This is an open access aparameter in the transmission of the biological information and the
determination of cellular fate [3, 4]. Live-cell imaging is the only tech-
nique that can capture the temporal evolution of individual cells. How-
ever, more tools are required to enable the quantification of signaling
activity in single cells in order to uncover novel biochemical regulations
in signal transduction cascades.
In mammalian cells, quantification of kinase activity is of particular
interest for signal transduction studies, because more than one third of
cellular proteins have identified phosphorylation sites [5]. Among these
kinases, Mitogen-Activated Protein Kinases (MAPKs) play a central role
in the signaling network of the cell. These proteins are evolutionary
conserved serine/threonine kinases that mediate a wide range of cellular
processes, including cellular growth, differentiation, adaptation to stress,
apoptosis or motility [6, 7, 8, 9]. MAPKs can be activated by a wide range
of extracellular signals. These environmental cues are typically detected
by membrane sensors, which relay this information inside the cell to the
MAPK signaling cascades. These cascades consist of three-core kinases
(MAP3K, MAP2K, and MAPK) with sometimes an additional upstream
MAP4K and a downstream MAPK-associate protein kinase. Once acti-
vated, the MAPK phosphorylates a wide array of substrates to modulateember 2020
rticle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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phosphorylation, therefore the specificity of the process is achieved via
distinct protein-protein interaction domains. One conserved interaction
motif is the docking site (DS), which is present in many substrates and
activators of the MAPKs [10, 11, 12]. In addition to the phosphorylation
of substrates, MAPKs are tightly implicated in the induction of specific
transcriptional program that can profoundly alter the cellular state.
In mammalian cells, three distinct groups of MAPKs have been
described: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal
Kinase (JNK) and p38 [13, 14, 15]. The analysis of targeted mutations in
mice, and the development of specific inhibitors have begun to shed light
on the function of these cascades in mammals. As MAPKs regulate mul-
tiple central cellular processes, misregulation of MAPK signaling is
implicated in the induction and progression of a broad range of diseases.
Indeed, deregulation of the ERK pathway has been identified in
approximately one third of all human cancers. The ERK pathway has
been shown to be implicated in multiple fundamental cellular processes
such as cell cycle entry, proliferation and differentiation [16]. In this2
cascade, ligand-mediated activation of a receptor tyrosine kinase triggers
the Ras GTPase, which recruits and activates the MAP3K RAF. In turn,
RAF phosphorylates and activates the MAP2K MEK, which finally acti-
vates the MAPK ERK. This kinase further relays the signal to many sub-
strates. Among these substrates, there are several key transcription
factors that will modulate the expression of genes implicated in cell fate
decisions [17, 18].
Due to the important role played by MAPKs in cellular fate determi-
nation and cancer progression, the ability to quantify their activity in live
single cells is highly required. Numerous FRET bio-reporters have been
developed and are commonly used to track the real-time kinase activities
in single cells [19, 20, 21, 22]. To obtain a robust FRET signal, a large
change in conformation between the active and inactive state of the
molecule is required. Unfortunately, in practice these changes are often
small and require a tedious optimization procedure to be improved [23].
In addition, the FRET probes block two fluorescent channels of the mi-
croscope, therefore limiting their application to monitor multiple cellular
activities within the same cell.Figure 1. Principle and development of
synthetic kinase activity relocation sensor
(SKARS) to monitor MAPK activity in
mammalian cells. a. Scheme of the SKARS
relocation process. When the kinase is inac-
tive, the NLS is functional and the sensor
accumulates in the nucleus. When the kinase
is active, it phosphorylates the SKARS, which
relocates into the cytoplasm. b. The ERK-
SKARS contains three domains: the ERK
docking site (MEK2 1–40), the two Nuclear
Localization Sequences (NLS), and the fluo-
rescent protein for visualization. Residues
involved in interaction, nuclear import or
phosphorylation are shown in cyan, red and
green, respectively. c. Representative micro-
scopy images of HeLa cells expressing the
ERK-SKARS cells and stimulated with EGF
(50 ng/ml) for 1 h period. In the red channel,
the ERK-SKARS translocates from the nu-
cleus to the cytoplasm. Nuclei are identified
by a Hoechst staining. d. After quantification
of the time-lapse movies, the ratio of the
average cytoplasmic fluorescence of the
average nuclear fluorescence (Cyto/Nucl
ratio) is plotted as function of time. For all
similar figures in this paper, the solid lines
represent the median of the cell population
and the shaded area the 25 and 75 percen-
tiles of the population. The dotted lines
represent a few single-cell traces extracted
from the cell population. More than hundred
single cells measured were plotted in the
graph. The red curve represents HeLa cell
treated with 50 ng/ml EGF (Number of cells:
Nc ¼ 340) and the green curve, mock-treated
control cells (Nc ¼ 449). e. Cyto/Nucl ratios
of HeLa cells expressing the ERK-SKARS
exposed to EGF stimulation (50 ng/ml) and
ERK inhibition (FR 180204, 50 ng/ml) are
plotted as function of time. EGF and ERK
inhibitor were added at the time points
indicated by the arrows. f. and g. HeLa cells
expressing the JNK-SKARS (f) and the p38-
SKARS (g) were treated with (red) and
without (green) Anisomycin (50 ng/ml). The
Cyto/Nucl ratio is plotted as function of
time.
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novel biosensors based on fluorescent protein relocation have been
developed. One strategy is to modulate the shuttling of a fluorescent
protein between the nucleus and the cytoplasm by phosphorylation. In
mammalian cells, the KTR (Kinase Translocation Reporter) was devel-
oped to monitor ERK, JNK and p38 activities [24]. In yeast cells, the
SKARS (Synthetic Kinase Activity Relocation Sensor) has been engi-
neered to monitor MAPK activity in the mating and cell wall integrity
pathways [25]. More recently, a new strategy based on protein aggre-
gation has been presented [26], where the phosphorylation of a synthetic
substrate by the kinase leads to the formation of bright fluorescent foci.
One key advantage of these reporters is that they occupy a single fluo-
rescent channel in the microscope. The combination of multiple fluo-
rescent sensors within a single cell becomes feasible allowing the
correlation of various signaling activities within the same cell [24, 27].
In this paper, we have adapted the SKARS approach to quantify ERK,
JNK and p38 activities in mammalian cells. We verified that this sensor
provides an improved readout compared to the KTR reporter by co-
expressing both sensors in the same cells. This biosensor allows to
monitor complex signal transduction dynamics in single cells that display
a large heterogeneity. In addition, we show that it can be applied to a
wide range of cell types in vitro and in developing tumors in vivo.
2. Results
2.1. The concept of SKARS biosensors for mammalian MAPK signaling
Nuclear Localization Signals (NLSs) are small amino acid sequences
that confer on proteins the ability to be transported in the nucleus. These
domains are highly conserved throughout eukaryotes, and for instance
the same SV40 NLS motif is commonly used in yeast as well as in
mammalian cells. NLSs are positively charged peptides and often consist
of a mix of four lysines or arginines. These positive charges enable a
strong interaction with the importin, which will promote the transfer of
interacting proteins through the nuclear pores into the nucleus [28]. The
amount of nuclear enrichment is directly linked to the ability of the NLS3
to bind to the importin [29]. Point mutations in the NLS consensus
sequence introducing uncharged amino-acids decrease the accumulation
in the nucleus. Similarly, addition of negatively charged residues in the
vicinity of the positively charged patch weakens the nuclear enrichment
[30]. Many transcription factors possess phosphorylation sites in the
vicinity of an NLS in order to control their nuclear enrichment in
response to signaling events [31, 32, 33].
Our SKARS biosensors aim at mimicking this behavior. We express in
the cell a synthetic substrate for a MAPK that can shuttle between the
cytoplasm and the nucleus based on its NLS phosphorylation status. We
combine two NLSs in order to promote a strong enrichment of the
biosensor in the nucleus under basal conditions. Both NLSs bear two
MAPK consensus phosphorylation sites (SP). The specific phosphoryla-
tion of the serines is controlled by the presence of a MAPK docking site
(DS) placed nearby [34, 35]. These short peptides forming the docking
modules are well known to steer the enzymatic activity of the MAPK
towards specific proteins and exchanging these sequences between
different proteins will alter the regulation by the MAPK [10]. Finally, a
fluorescent protein is functionalized with the DS and the NLSs to generate
our reporter. In the absence of kinase activity, the fluorescence signal will
accumulate in the nucleus thanks to the NLSs; while in the presence of an
activeMAPK, the phosphorylation of this synthetic substrate will result in
its relocation into the cytoplasm (Figure 1a).2.2. Quantification of endogenous ERK activity by the ERK-SKARS
In order to adapt our previously developed yeast SKARS biosensor to
report on mammalian MAPK activity, only the MAPK specific interaction
module had to be changed. The 2xNLS peptide and the fluorescent pro-
teins remained identical. Remarkably, the ability to use the same func-
tional part of the sensor strongly suggests that this reporter could be
applied to a diverse range of eukaryotes. The docking site, however,
should be adapted for each MAPK of interest to ensure the specificity of
the interaction. In mammalian cells, these interaction domains have been
extensively studied and many candidate DS motifs are described in the
literature. In order to target the ERK pathway, we selected a DS for ERK2Figure 2. Direct comparison of ERK-SKARS
and ERK-KTR in the same cells. a. Repre-
sentative microscopy images of single HeLa
cells carrying ERK-SKARS (red) and ERK-
KTR (green) exposed to stimulation (EGF
50 ng/ml) and imaged at indicated time
points. b. Histogram of SKARS and KTR nu-
clear enrichments before (Nucl/Cyto) of
HeLa cells expressing ERK-SKARS (red) and
ERK-KTR (green) before stimulation (mean
of three first time points). c. Median (solid
line) and 25- to 75-percentile (area) of the
Cyto/Nucl ratios from ERK-SKARS (red) and
ERK-KTR (green) upon stimulation by 10 ng/
ml EGF. The single cell traces were normal-
ized to the basal level (the mean of the first 3
three time points) (Nc ¼ 234). d. Single cell
traces of the Cyto/Nucl ratios for ERK-SKARS
(solid line) and ERK-KTR (dashed line) were
plotted as function of time. Each color rep-
resents the measurements from one single
cell, and both reporter traces for each cell are
displayed.
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this protein (Figure 1b) [35].
The ERK-SKARS was cloned into a lentiviral vector and lentiviruses
were produced to infect HeLa cells to generate cells stably expressing our
construct. As shown in Figure 1c, the inactive form of the sensor accu-
mulates in the nucleus of HeLa cells incubated in starved medium. Upon
EGF stimulation (50 ng/ml), the ERK signaling cascade is activated and
the MAPK can phosphorylate the serines in the vicinity of the NLS on the
sensor. This leads to a rapid redistribution of ERK-SKARS to the cyto-
plasm. As illustrated in Figure 1c, six minutes after the stimulus, the
nuclei of the two cells from the picture are strongly depleted from the4
bioreporter, providing a qualitative readout of MAPK activity in these
cells.
In order to obtain quantitative measurements, time-lapse movies
were automatically analyzed [36]. A DNA staining dye (Hoechst) was
used to automatically segment the nuclei, allowing to quantify the fluo-
rescence intensity of the SKARS in the nucleus. The intensity in the
cytoplasm is extracted from a ring surrounding the nucleus. The ratio of
the cytoplasmic over nuclear intensities in each single cell is used as a
proxy for MAPK activity. In Figure 1d, the median and 25-, 75-percentiles
of the population response are plotted for more than 300 single cells
stimulated with 50 ng/ml EGF and for an unstimulated control (PBS).
Before stimulation, the ERK-SKARS is enriched in the cell nucleus,Figure 3. Cellular heterogeneity in ERK ac-
tivity upon stimulation with high concen-
tration of EGF. a. Heat map of the response of
individual cells to a stimulation with EGF (50
ng/ml) in single clonal HeLa cells expressing
the ERK-SKARS. Each line represents the
cytoplasmic to nuclear ratio of one single cell
normalized to the first three time points
before stimulation. The cells were sorted
using k-mean clustering (See Methods). The
different sub-populations are identified by
the five colored bars on the right of the map.
b. Median of the normalized Cyto/Nucl ra-
tios from the indicated subgroups identified
in the population. c. Histograms of the basal
Cyto/Nucl ratios measured in the five sub-
groups. d., e. and f. Representative micro-
scopy images of HeLa cells expressing the
ERK-SKARS from three different sub-
populations (A, B, D). The right panel dis-
plays the Cyto/Nucl measurements of five
single cells from that sub-population (dashed
lines). The thin solid line corresponds to the
single cell identified in the microscopy im-
ages on the left with an asterisk. The thick
solid line represents the mean response from
the sub-population.
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After EGF addition, the ratio increases suggesting that the sensor has
been phosphorylated by active ERK in response to the EGF stimulation,
leading to its shuttling from the nucleus to the cytoplasm. The ratio re-
mains high for the 60-minute duration of the time lapse (Figure 1 c and
d). This sustained activation of ERK signaling upon high EGF treatment is
also observed by Western blot and immunofluorescence staining (Sup
Figure 1). These two techniques are routinely used to quantify ERK ac-
tivity but they provide snapshot measurements of the cellular signaling5
state at specific time points. In comparison, the SKARS reporter provides
a dynamic readout of kinase activity in live single cells.
2.3. Specificity of the ERK-SKARS
To demonstrate the specificity of our SKARS readout, we performed a
number of control experiments. First, the four serines present in the NLSs
were mutated to either non-phosphorylable (NLS-4A) or phospho-
mimicking mutants (NLS-4E) (Sup Figure 2a and b). As expected, the
NLS-4A is constitutively enriched in the nucleus (low Cyto/Nucl ratio),Figure 4. Monitoring of ERK activity
pulses upon low doses of EGF. a. Median
Cyto/Nucl ratio of ERK-SKARS in more
than 400 single cells from a clonal HeLa
cell population stimulated with low
doses of EGF and monitored for more
than 3 h b. Fraction of cells identified in
the experiment from panel 4a that
display three pulses or more in ERK ac-
tivity. c. Heat map of the Cyto/Nucl
ratio measured upon 0.1 ng/ml EGF
treatment in HeLa cells. Only cells
where three or more pulses were iden-
tified are displayed in this graph. d.
Microscopy images of HeLa cell dis-
playing pulses in ERK activation upon
0.1 ng/ml EGF stimulation. e. Various
examples of single cell traces displaying
fluctuations in ERK activation upon 0.1
ng/ml EGF treatment.
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addition, both mutants lose the ability to respond to the EGF stimulus,
thereby confirming that the phosphorylation of the four serines is con-
trolling the nuclear localization of the sensor. Second, the five key resi-
dues in the docking site were mutated to alanine (non-docking MEK2,
MEK2ND) (Sup Figure 2c). In the same cells, we compared the response of
the non-docking mCherry SKARS and a functional sensor with a GFP
fluorophore. While the reporter bearing the DS of MEK2 displayed the
expected relocation from the nucleus into the cytoplasm, the ND reporter
localization remained unchanged upon the addition of EGF (Sup
Figure 2d to f), indicating a clear specificity of the substrate for the kinase
interaction and phosphorylation of the substrate. Interestingly, these
experiments also demonstrate that, while mutations in the DS or the NLS
alter the function of the sensor, the fluorescent protein can be exchanged
without perturbing the ability of the reporter to relocate. This feature
allows to rapidly adapt the SKARS to specific imaging requirements and
enables the combination of multiple sensors in the same cell.
To further validate the specificity of the ERK-SKARS reporter, a direct
selective inhibitor of ERK (FR180204 [37]) was applied to block the
phosphorylation activity of the MAPK. The addition of the ERK inhibitor
45 min after the EGF stimulus led to a rapid return of the sensor into the
nucleus (Figure 1e). In comparison, ERK activity was sustained for more
than 80 min in the control cells. In addition, pretreatment of the cells
with the same ERK inhibitor abolished the EGF-stimulated translocation
of the ERK-SKARS (Sup Figure 3a). In contrast, cells pretreated with JNK
or p38 inhibitors displayed an unperturbed relocation of the ERK sensor
upon EGF stimulation (Sup Figure 3b and c). Taken together, these results
demonstrate that the ERK-SKARS can efficiently and reliably quantify
ERK kinase activity in live single mammalian cells.2.4. JNK and p38 SKARS
In order to change the specificity of a substrate from ERK towards JNK
or p38, its docking site can be swapped [35, 38]. We selected docking
sites present in downstream transcription factors of the two MAPKs
(c-Mef2 for p38 and c-jun for JNK) to replace theMEK2 docking sequence
of the ERK-SKARS (Sup Figure 4). Using lentiviral vectors, we generated
HeLa cell lines stably expressing either JNK-SKARS or p38-SKARS. As
expected, anisomycin stimulation resulted in a fast translocation of both
sensors into the cytoplasm (Figure 1f, g, and Sup Figure 4). Interestingly,
the dynamics of the responses were very different for the two kinases.
While anisomycin induced a sustained activation of the JNK pathway,
p38 signaling was only transiently activated for 30 min, in agreement
with previous observations [39]. This experiment demonstrates the
robustness and versatility of these relocation sensors. Modulating their
specificity simply by the substitution of the docking site, offers the op-
portunity to target kinases with similar modes of action (for example
CDK) or adapting the reporter to other organisms.2.5. Comparison of KTR and SKARS for the quantification of kinase
activity
The design of our sensors bears many similarities with the KTR system
[24]. Therefore, in order to compare the relative abilities of the SKARS
and the KTR to quantify MAPK activity, we generated cells stably
expressing both reporters (Figure 2a). Both sensors were made spectrally
compatible with an ERK-SKARS based on an mCherry protein, while the
ERK-KTR was coupled to an mClover protein (a GFP variant). These two
constructs are based on two different ERK DS: MEK2 for the SKARS and
ELK1 for the KTR. But the major difference between these reporters re-
sides in the peptides that control the nuclear to cytoplasmic shuttling.
Indeed, the KTR combines an NLS and an NES (Nuclear Export Signal).
The kinase activity drives the export of the construct because the phos-
phorylation weakens the NLS and enhances the efficiency of the NES. In
comparison, for the SKARS, only the nuclear import rate is modulated by6
the phosphorylation of the NLS, and the sensor relies on the natural
diffusion through the nuclear pores to exit the nucleus.
To standardize the expression levels of both reporters, we focused our
analysis on cells expressing both constructs at intermediate levels (Sup
Figure 5a). In these cells, the nuclear enrichment of the SKARS in basal
condition is higher than for the KTR (Figure 2b, Sup Figure 5b, Sup
Table 1). In order to directly compare the responses of both sensors in the
same cell, single cell traces were normalized to their basal levels (mean of
the first three time points before stimulus). As shown in Figure 2c, when
cells were stimulated with EGF, both ERK-SKARS and ERK-KTR sensors
could rapidly translocate from the nucleus to the cytoplasm, leading to a
rapid increase of cytoplasm to nucleus ratio (Figure 2c and Sup
Figure 5c). However, relative to the ERK-KTR population response
amplitude (1.5 folds on average), the cytoplasm-to-nucleus ratio change
is larger for the SKARS sensor (2 fold on average). At the single-cell level,
the traces for both sensors in the same cell were comparable but the
amplitude of the SKARS response was generally larger (Figure 2d and Sup
Figure 5d). Similar results were obtained when comparing the JNK-
SKARS and the JNK-KTR in the same cells (Sup Figure 6). Note that in
the case of the JNK reporters, both sensors are based on the same docking
site, thus the difference in relocation observed stems only from the
phosphorylated part of the sensor. Because both techniques measure the
ability of the MAPK to promote the translocation of the reporter out of
the nucleus, starting with a higher nuclear pool of SKARS sensors pro-
vides a better dynamic range for the SKARS design compared to the KTR
system.2.6. Single cell analysis of the dynamics of ERK activity
After validation of the ERK-SKARS reporter in mammalian cells, we
wanted to assess how much heterogeneity in ERK activity existed within
a population of isogenic cells. In order to achieve this, we isolated single-
cell clones by serial dilution (See Methods). Three different cell lines
bearing the ERK-SKARS were isolated and imaged. Since they displayed
similar behaviors (data not shown), the data from only one of these lines
are presented here.
First of all, we noticed that individual cells displayed a large vari-
ability of nuclear sensor enrichment before the EGF stimulation in
starved medium, suggesting that different basal activities of ERK are
present in each cell. Despite this diversity, upon stimulation with a
saturating concentration of EGF, the majority of the population displayed
a strong ERK activation. In order to detect different activity patterns in
the cellular responses, the cytoplasm to nucleus ratios of the cells were
normalized between their basal values (average of the first three time
points) and maximum values. K-mean clustering was applied to separate
the traces into four sub-populations. A fifth sub-population consists of
non-responding cells (relocation less than 0.05) has been removed from
the analysis prior to the k-mean clustering. Figure 3a displays the
response of almost 500 cells quantified in this experiment in a heat map.
Each line corresponds to the normalized cytoplasm to nucleus ratio of a
single cell. The traces were grouped in their individual clusters. Figure 3b
displays the median dynamics of ERK activation in the five sub-
populations.
Interestingly, the two sub-populations with the weakest responses
(Figure 3d, e, clusters A and B) display a higher basal cytoplasm to nu-
cleus ratio (Figure 3c). This suggests that these cells already possess a
substantial ERK basal activity and further activation of the pathway with
EGF only leads to a minor increase in kinase activity. In the other three
clusters (Clusters C, D and E, Figure 3f and Sup Figure 7a and b), a strong
activation of the pathway is observed with some variability in the dy-
namics of signaling activity following the stimulus for each cluster.
Heterogeneity is present within a population of isogenic cells in part due
to differences in cell-cycle stages [40] and the SKARS offers the ability to
visualize cell-to-cell variability and understand how it can impact the
cellular response.
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We next wanted to assess the activity of the ERK pathway at more
physiological concentrations of EGF [41, 42]. The clonal cell line
expressing the ERK-SKARS was stimulated with EGF concentrations
ranging from 0.01 ng/ml to 2.5 ng/ml (Figure 4a and Sup Figure 8a–c).
Interestingly, around 0.1 ng/ml EGF, in a sub-population of the cells,
strong oscillations in ERK activity are observed. At 0.1 ng/ml EGF, almost
half of the population display at least three peaks (Figure 4b, Methods).
At lower or higher concentrations, the oscillatory behavior tends to
disappear and no oscillations were detected in cells stimulated with EGF
2.5 ng/ml or higher. The heat map in Figure 4c represents the cyto-
plasmic to nuclear ratio of the sub-population of cells stimulated with 0.17
ng/ml where three or more peaks were identified. While the oscillations
of individual cells can be visualized in this heat map, no global pattern
emerges, indicating an asynchronous oscillation of the cells in the pop-
ulation. Indeed, when plotting individual single cell traces or looking at
individual cells (Figure 4d,e, þ Sup Movie 1), the ERK activity pulses
seem highly stochastic.
Multiple studies have uncovered oscillations in ERK activities [43, 44,
45, 46]. Some of these oscillatory patterns were observed with periods on
the hour time-scale and were linked to the proliferation of the cells. The
behavior we observe is happening on the tens of minutes time-scale. It is
reminiscent of the ERK nuclear relocation pulses observed by Shankaran
and co-workers when monitoring the MAPK tagged with YFP upon
stimulation with 1 ng/ml EGF [46]. Interestingly, this signaling pattern isFigure 5. SKARS measurements performed in
cancer and primary cell lines. a to d. Left panels
show representative microscopy images of SCC13
(a), MCF7 (b), MDA-MB231 (c), HFF (Human
Foreskin Fibroblast) (d) cells expressing the ERK-
SKARS and stimulated with EGF (50 ng/ml). The
right panels show the Cyto/Nucl ratio in the
respective cell lines. Quantifications of the time-
lapse movies for samples treated with EGF are
plotted in red and control samples in green. For
each trace, more than 100 single cells measure-
ments were combined to generate the graphs.
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did not display this oscillatory behavior (data not shown). This fast
translocation of the SKARS between the nucleus and the cytoplasm al-
lows to monitor in real time the fluctuations in MAPK activity.
2.8. SKARS in various cells types
All the above results show that the SKARS biosensors provide an
efficient and reliable strategy to quantify the MAPK activity. In order to
demonstrate the applicability of our sensor to various cell types, we
tested the ERK-SKARS in cancer cell lines (Figure 5a–c), primary cells
(Figure 5d), primary neuronal cells, as well as, stem cells (data not
shown). In the MDA-MB231 cancer cell line, we do not observe a
response to EGF stimulus of the ERK-SKARS reporter because this cell line
lacks HER2 (Human Epidermal growth factor Receptor 2) expression
[47]. Thus, EGF stimulation cannot induce ERK signaling activation
(Figure 5c). In all other cell types tested, a strong and sustained response
to EGF stimulus is observed and large heterogeneity in the single cell
responses can be monitored, as previously observed in the HeLa cells.
These results confirm that the SKARS reporter offers a robust assay to
quantify ERK activity in diverse samples.
2.9. In vivo measurement of kinase activity with ERK-SKARS
Misregulation of MAPK signaling has been observed in numerous
diseases, especially in human cancers [48, 49]. A better understanding of8
cancer progression as well as MAPK pathway target therapy will un-
doubtedly require the ability to study signaling pathway activity in
developing tumors. Currently, the most common way to quantify kinase
activity in tissues remains immunohistochemistry. It is a complex and
time-consuming method whose sensitivity is highly dependent on the
specificity of the antibody and on sample preparation. Moreover, it only
provides a snapshot measurement of signaling activity in the tissue. With
the advent of novel microscopy techniques, it becomes feasible to image
living cells directly in these complex environments [50, 51, 52].
To test the application of the ERK-SKARS in vivo, we used a skin
cancer orthotropic model, based on mouse ear intradermal injections of
tumorigenic Squamous Cell Carcinoma (SCC) cells [53]. We injected
SCC13 cells expressing ERK-SKARS into the ears of 8- to 10-week-old
female mice (Severe Combined Immuno Deficiency, SCID, CB17sc-m).
After 14 days of growth, the cells formed a small tumor. The tissue was
excised into 10–20 μm slides by Vibratome (Leica VT1200/S), stained
with Hoechst and then imaged by confocal microscopy. Figure 6a shows
the SCC13 cells (red) surrounded by the mouse-ear tissue (green). SCC13
cells displayed different levels of nuclear enrichment of the sensor in vivo,
indicating that ERK is activated to different extents in these cells. In order
to verify the activity of ERK in these settings, we performed another
experiment where the SCC13 cells injected in the mouse ear were
expressing a functional (MEK2DS) and a non-functional (MEK2ND) re-
porter (Figure 6b) as an internal control. In this situation, the lower
nuclear enrichment of the ERK-SKARS in the GFP channel relative to the
control in the RFP channel can provide a direct measure of kinase activityFigure 6. Application of SKARS for kinase ac-
tivity quantification in tissue. a. Confocal images
of HeLa cells expressing ERK-SKARS (red) in
tumor implanted in a mouse ear. The green
channel represents the nuclei of the cancerous
and normal tissues, which were stained with
Hoechst. The inset is a magnification of the image
to display cells with different levels of nuclear
accumulation of relative to the nuclear staining.
Asterisk highlight cells with higher ERK activity.
b. Confocal images of SCC13 cells expressing
ERK-SKARS-GFP (MEK2DS, green) and MEK2ND-
2xNLS-mCherry (red) in tumor implanted inside
of mouse ears. Asterisk highlight cells with higher
ERK activity.
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activity read-out will allow to expand the ability to monitor MAPK
signaling in cancer progression or during development.
3. Conclusion
The SKARS and KTR relocation strategy provides a global measure-
ment of kinase activity in a cell in real time. With the addition of a nu-
clear marker, the quantification of signaling dynamics in hundreds of
single cells can be automated. In comparison, the SPARK reporter dis-
plays a clear visual readout for MAPK activity. However, with this assay,
the quantification of the signal is more challenging due to a non-uniform
spatial readout, which complicates its automated measurement in single
cells. FRET biosensors can also provide quantitative readout of signaling
activity. Compared to the sensors cited above, it has the unique ability to
monitor local changes in kinase activity [54, 55]. For some studies, FRET
biosensors might therefore have the advantage of adding a spatial in-
formation for signaling activity. However, in more complex imaging
conditions, such as tissues or in changing environment, the SKARS can
potentially offer a better option by providing a robust readout of MAPK
activity. In addition, multiple relocation biosensors can be combined in
the same cell, allowing to monitor multiple steps within a signal trans-
duction cascade or to correlate the signaling dynamics between different
pathways.
4. Methods
Supplementary Table 2 summaries the chemical reagents and bio-
logical materials used in this study.4.1. Mouse strain
NOD/SCID mice with interleukin-2 receptor gamma chain null mu-
tation (Il2rg /) were maintained in the animal facility of the Uni-
versity Lausanne. All mouse work was carried out according to the Swiss
guidelines and regulations for the care and use of laboratory animals,
with approved protocol from the Canton de Vaud veterinary office.4.2. Human samples
Primary Human Foreskin Fibroblasts (HFF) were extracted from the
discarded human tissue samples obtained from the Department of Pedi-
atrics, at Lausanne University Hospital, with institutional approval and
informed consent as part of institutional requirements.4.3. Cell culture
The cell lines and the primary cells were cultured and passaged in
Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 100
μg/ml streptomycin, 100 units/ml penicillin, 0.25 μg/ml amphotericin B
(15240062, Gibco) and 10% heat inactivated Fetal Bovine Serum (FBS,
10270106, Gibco).4.4. Plasmids construction
All the SKARS plasmids for this study are constructed following to
standard molecular biology protocol and the vector sequences were
confirmed by exhaustively sequencing the cloned fragment. SKARS
plasmids were constructed by cloning the docking site for the kinase of
interest, the synthetic 2xNLS and the fluorescent protein of the sensor
into a Lentiviral Vector backbone plasmid (pLV, a generous gift from
Olivier Pertz, University of Bern).9
4.5. Cell line generation
Stable cell lines expressing the sensor of interest were generated by
lentiviral transduction. Lentiviral vectors together with third generation
packaging plasmids were transfected into 293T cells to generate lenti-
viruses. Packaged lentiviruses containing supernatants were added to
recipient HeLa cells in the presence of 10 μg/ml Polybrene (AL-118,
Sigma-Aldrich). At 3–5 days post transduction, cells were sorted based on
fluorescent protein expression by flow cytometry (FACSAria III, BD
Biosciences). After sorting, cells were cultured in DMEM. This medium is
referred to as complete medium. The starvation medium is completed
only with 0.5% FBS. Cells were cultured at 37 C in a humidified at-
mosphere containing 5% CO2. Singe-cell clones were isolated by serial
dilutions of cells in a 96-well plate. To make sure that the colonies arose
from single cells, the single-cell colonies isolated have been re-cloned for
a second time.
4.6. Sample preparation and time-lapse imaging
The day before the time-lapse experiment, 10,000 cells/well of HeLa
cells expressing the desired constructs were seeded onto the 96 well glass
bottom optical imaging microplate (MGB096-1-2LG, Matrical Biosci-
ence) coated with 10 μg/ml fibronectin (33010-018, ThermoFisher). 2
hours before the microscopy experiment, medium was replaced with
Gibco FluoroBrite DMEM medium (A1896701, Gibco) supplemented
with GlutaMAX, HEPES, sodium pyruvate and 0.5% FBS. For nucleus
staining, we incubate the cells with 10 ng/ml Hoechst 33342 (H3579,
Molecular Probes) for 1 h.
Images were acquired on a fully automated inverted epi-fluorescence
microscope (Ti-Eclipse, Nikon) controlled by micro-manager [56] using a
20X air objective and appropriate excitation and emission filters. The
excitation is provided by a solid-state light source (SpectraX, Lumencor).
The images were recorded with an sCMOS camera (Flash 4.0, Hama-
matsu). A motorized XY-stage allowed recording multiple fields of view
at every time point. GFP (50 ms), RFP (50 ms), DAPI (30 ms) and a
bright-field (30 ms) images were recorded at time intervals varying from
2 to 3 min. During the experiments, the temperature (37 C), the CO2
(5%) and the humidity (95%) were kept constant using a
temperature-controlled chamber and a CO2 controller (Cube and Brick,
Life Imaging Service). Stimulations and chemical inhibitors were care-
fully added to the cells in the incubation chamber after the time-lapse
imaging started. To activate ERK signaling, 50 ng/ml (or lower concen-
trations, where specified) EGF was added. To demonstrate the specificity
of the SKARS-ERK, cells were pre-incubated with DMSO, MEK inhibitor
(PD032591 100 nM), p38 inhibitor (p38 inhibitor 10 μM) and JNK in-
hibitor (JNK inhibitor VIII, 10 μM) for 30 min before imaging and
stimulation. To inactivate the ERK signaling, ERK inhibitors were added
45 min after the EGF stimulation. To activate JNK and p38 signaling,
Anisomycin 50 ng/ml was added to the cells.
4.7. Data analysis
Time-lapse movies were analyzed with the YeastQuant platform [36].
The cell nucleus and a 10-pixel-wide cytoplasm ring were segmented for
each cell using the Hoechst image as a reference and quantified in each
channel. The cell nucleus was tracked across all the frames of the movie.
Multiple features of each cell were quantified. For each cell, the average
nuclear intensity and the 10-pixel-wide cytoplasm ring in the fluorescent
channel corresponding to the SKARS signal were extracted and used to
calculate the cytoplasm to nucleus ratio providing a measure of kinase
activity in each cell.
Data were further processed using Matlab software (R2017b, Math-
Works). For quality control, among all cells tracked over the whole time-
lapse experiment, only the cell traces with low variability in nuclear size
and intensity were kept for further analysis. The basal level was calcu-
lated as the mean of the first three time points of the cytoplasm to nucleus
M. Ma et al. Heliyon 6 (2020) e05574ratio. To cluster the cellular responses in different sub-populations, the
non-responding cells were first identified by selecting cells with a change
in Cyto/Nucl ratio smaller than 0.05. The other single cell traces were
normalized between basal and maximal Cyto/Nucl ratio after stimulus.
These normalized traces were fed to the kmeans function and the best
clustering from 50 iterations was selected. In order to identify the pulses
in the traces at low EGF concentrations, the single cell traces were passed
to the findpeaks function. Only pulses (¼peaks) with a minimal promi-
nence of 0.2 were taken into consideration.4.8. Immuno-blotting (IB)
Total proteins were extracted with modified RIPA lysis buffer (50 mM
Tris pH 7.4, 150 mM NaCl, 1 mM EDTA pH 8.0, 1% 1X NP40, 0.25% NA-
deoxycholate, 2 mM Na-vanadate, 5 mM NaF, 1X protease inhibitors
cocktail B (Santa Cruz, sc-45045)). Proteins were separated by SDS-PAGE
gel, transferred onto PVDF membrane (Millipore), probed with primary
antibody followed by HRP-linked secondary antibodies and detected by
SuperSignal west pico chemiluminescent substrate (Thermo Scientific).
The primary antibodies used for immunoblotting were rabbit anti-ERK1
Antibody (C-16) Santa Cruz sc-93 (1:1000), ERK2 Antibody (C-14) Santa
Cruz sc-154 (1:1000), anti-GAPDH Antibody FL-335 Santa Cruz sc-25778
(1:1000), and anti-Phospho-p44/p42 MAPK (Erk1/2) Antibody
(Thr202/tyr204) (D13.14.4E) XP Rabbit mAB (Cell Signaling, 4370).
Anti-rabbit antibody (Rabbit IgG, HRP-linked whole Ab from donkey,
Amersham NA 934) was used as a secondary antibody. After the detec-
tion of Phospho-ERK1/2, the membrane was stripped with stripping
buffer (0.05 M Tris pH 6.8, 2% SDS, 0.8% beta-mercaptoethanol) for 30
min at 50 C before detecting total ERK1 þ ERK2.4.9. Immunofluorescence analyses (IFA)
10,000 cells were seeded onto a 13 mm glass coverslip in 24-well
glass bottom plate coated with 10 ng/ml fibronectin. The next day, me-
dium was replaced to starved medium and cultured for 1 h, then the cells
were stimulated for indicated times and fixed with 4% para-
formaldehyde. After washing 3 times by PBS at room temperature, cells
were permeabilized with 0.5% Triton X-100 in PBS for 10 min. Blocking
of nonspecific epitopes was performed in blocking buffer (10% FBS in
PBS) for 15 min at room temperature. The primary antibodies were
applied at 1:100 dilutions in blocking buffer at 4 C overnight. The
fluorophore-conjugated secondary antibody (Donkey anti Rabbit IgG (H
þ L), Alexa Fluor 488 Thermo Fisher Scientific A-21206) and Hoechst
33342 were applied at 1:1000 dilutions in blocking buffer for 1–2 h at
room temperature in the dark. Images were acquired by Zeiss LSM 880
confocal microscope, and the images were processed with the FIJI
software.4.10. Animal experiment: intradermal ear injection and imaging
Mouse-ear injections of cells were carried out in 10-week-old male
NOD/SCID mice with interleukin-2 receptor gamma chain null mutation
(Il2rg /). SCC cells expressing the ERK-SKARS-mCherry or ERK-
SKARS-GFP and MEK2ND-SKARS-mCherry were cultured in 10 cm
dishes for 50–60 % confluence. After trypsinization and centrifugation,
SCC13 cells were resuspended in 3 μl of sterile Hank's Balanced Salt
Solution, and injected intradermally in mouse ears through a 33-gauge
microsyringe (Hamilton). Mice were sacrificed 3 weeks later for live
tissue imaging analysis. Fresh tumors were sectioned into <1 mm slices
and further analyzed through an inverted confocal microscope (Zeiss
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